Gene · 4154
Papers2,262
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,262
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A single-cell and spatial transcriptomic atlas of human tuberculous constrictive pericardium. | EBioMedicine | 2026 | 41875497 | PubTator, text mining | PubMed |
| Commitment to Myogenic Differentiation Significantly Aggravates the RNA Phenotype in Myotonic Dystrophy Type 1. | Neuropathol Appl Neurobiol | 2026 | 41848171 | PubTator, text mining | PubMed |
| Delpacibart etedesiran improves the molecular pathology of myotonic dystrophy type 1 in the phase 1/2 MARINA study. | Mol Ther | 2026 | 41821312 | PubTator, text mining | PubMed |
| High-Grade Astrocytoma With Piloid Features: An Aggressive Clinicogenomic Entity Distinct From Pilocytic Astrocytoma. | J Korean Med Sci | 2026 | 41807027 | PubTator, text mining | PubMed |
| Targeting Expanded CUG and CTG Repeats as a Therapeutic Approach for Myotonic Dystrophy Type 1 (DM1). | ChemMedChem | 2026 | 41797662 | PubTator, text mining | PubMed |
| Mechanisms Underlying Aberrant Splicing of Transcripts From the Intron-Less Coding Sequence of SPCA1. | Genes Cells | 2026 | 41793167 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast-derived exosomal LINC00930 represses cell malignancy and glycolysis by recruiting MBNL1 and elevating PRKAA2 stability in colorectal cancer. | Eur J Med Res | 2026 | 41776698 | PubTator, text mining | PubMed |
| Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies. | Front Pharmacol | 2026 | 41769701 | PubTator, text mining | PubMed |
| Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma. | Sci Adv | 2026 | 41758938 | PubTator, text mining | PubMed |
| CELF1 Downregulation Promotes Cardiomyocyte Hypertrophy via Regulating Alternative Splicing of Tead1. | Genes (Basel) | 2026 | 41751542 | PubTator, text mining | PubMed |
| Elevated Risk of Endometrial Cancer and Precursor Lesions in Patients With Myotonic Dystrophy: A Retrospective Study at a Single Institution in Japan. | J Obstet Gynaecol Res | 2026 | 41744896 | PubTator, text mining | PubMed |
| Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosis. | Signal Transduct Target Ther | 2026 | 41741410 | PubTator, text mining | PubMed |
| Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1. | Am J Hum Genet | 2026 | 41722569 | PubTator, text mining | PubMed |
| Modified Polycyclic Compounds Rescue Mis-splicing in Myotonic Dystrophy Type 1 Disease Models. | ACS Chem Biol | 2026 | 41716008 | PubTator, text mining | PubMed |
| Identification of enzymatically modified isoquercitrin as a therapeutic lead for myotonic dystrophy type 1. | NAR Mol Med | 2026 | 41710065 | PubTator, text mining | PubMed |
| MBNL2 dysfunction in outer radial glial cells is associated with disrupted corticogenesis in congenital myotonic dystrophy. | Neurobiol Dis | 2026 | 41644016 | PubTator, text mining | PubMed |
| Aberrant skeletal muscle morphogenesis and myofiber differentiation characterize equine myotonic dystrophy. | PLoS One | 2026 | 41610137 | PubTator, text mining | PubMed |
| Isolation and typing techniques for circulating tumor cells. | Biomark Res | 2026 | 41606691 | PubTator, text mining | PubMed |
| The splice of life: how alternative splicing shapes regulatory and phenotypic evolution. | EMBO J | 2026 | 41545761 | PubTator, text mining | PubMed |
| Post-transcriptional control of HIF-1α by MBNL1 restrains hypoxia-driven stemness in GBM. | Neoplasia | 2026 | 41365085 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4154/papers?page=2